Bupropion Hydrochloride
- Product NDC
- 71335-1156
- 11-digit product format
- 713351156
- Labeler code
- 71335
- Product ID
- 71335-1156_373f0931-0e06-46cd-85ae-847bf286a8ed
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BUPROPION HYDROCHLORIDE
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA077415
- Marketing category
- ANDA
- Marketing start
- 2009-05-01
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1156-1 | 71335115601 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1156-1) | 2009-05-01 | 0000-00-00 | No | No | Current |
| 71335-1156-2 | 71335115602 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1156-2) | 2009-05-01 | 0000-00-00 | No | No | Current |
| 71335-1156-3 | 71335115603 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1156-3) | 2009-05-01 | 0000-00-00 | No | No | Current |
| 71335-1156-4 | 71335115604 | 120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1156-4) | 2009-05-01 | 0000-00-00 | No | No | Current |
| 71335-1156-5 | 71335115605 | 14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1156-5) | 2022-02-14 | 0000-00-00 | No | No | Current |